Author

L. Maillat

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Patnaik· 1 shared B. Heiss· 1 shared K. Chaudagar· 1 shared K. M. Bynoe· 1 shared P. D. Gupta· 1 shared S. Sharma-Saha· 1 shared W. Stadler· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Patnaik

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PARP and PI3K inhibitor combination therapy eradicates c-MYC-driven murine prostate cancers via cGAS/STING pathway activation within tumor-associated macrophages

P. D. Gupta, K. Chaudagar, S. Sharma-Saha, K. M. Bynoe, L. Maillat, B. Heiss, W. Stadler, A. Patnaik

This paper shows that combining PARP and PI3K inhibitors eradicates c-MYC-driven prostate cancer by activating the cGAS/STING pathway in tumor-associated macrophages.

bioRxiv · Jul 17, 2020 · PreprintCancer Biology